Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Sees Significant Growth in Short Interest

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) was the target of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 13,527 shares, an increase of 55.1% from the January 15th total of 8,723 shares. Based on an average daily volume of 20,855 shares, the days-to-cover ratio is presently 0.6 days. Approximately 1.5% of the company’s shares are short sold. Approximately 1.5% of the company’s shares are short sold. Based on an average daily volume of 20,855 shares, the days-to-cover ratio is presently 0.6 days.

Virtus LifeSci Biotech Clinical Trials ETF Stock Down 1.1%

Shares of NYSEARCA BBC traded down $0.43 during trading hours on Friday, reaching $39.87. The stock had a trading volume of 13,941 shares, compared to its average volume of 26,768. Virtus LifeSci Biotech Clinical Trials ETF has a 52-week low of $13.42 and a 52-week high of $44.10. The business’s fifty day moving average price is $40.17 and its two-hundred day moving average price is $32.12.

Virtus LifeSci Biotech Clinical Trials ETF Company Profile

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.